NIAID Banner Logo Image

Mycobacterium Citations List: February 2024

Literature Citations

1. An Adamantyl-caffeoyl-anilide Exhibits Broad-spectrum Antibacterial Activity by Inhibiting FtsZ Assembly and Z-ring Formation. Bhondwe, P., N. Sengar, H.S. Bodiwala, I.P. Singh, and D. Panda. International Journal of Biological Macromolecules, 2024. 259(Pt 2): 129255. PMID[38199552].
[PubMed]. TB_02_2024.

2. 19 Schiff Bases as Antimycobacterial Agents: Synthesis, Molecular Docking and a Plausible Mechanism of Action. Cai, Y.X., J.X. Chen, H.M. Dong, and Z.C. Yang. Future Medicinal Chemistry, 2024. 16(5): p. 453-467. PMID[38314562].
[PubMed]. TB_02_2024.

3. N-Substituted Piperazine-coupled Imidazo[2,1-b]thiazoles as Inhibitors of Mycobacterium tuberculosis: Synthesis, Evaluation, and Docking Studies. Chirra, N., N.P. Abburi, E.M. Rekha, R.K. Pedapati, R.K. Bollikanda, M. Murahari, D. Sriram, B. Sridhar, and S. Kantevari. Drug Development Research, 2024. 85(1): e22153. PMID[38349258].
[PubMed]. TB_02_2024.

4. Investigating Novel IspE Inhibitors of the MEP Pathway in Mycobacterium. Choi, S-R., and P. Narayanasamy. Microorganisms, 2023. 12(1): 18. PMID[38276186]. PMCID[PMC10819746].
[PubMed]. TB_02_2024.

5. Azetidines Kill Multidrug-resistant Mycobacterium tuberculosis Without Detectable Resistance by Blocking Mycolate Assembly. Cui, Y., A. Lanne, X. Peng, E. Browne, A. Bhatt, N.J. Coltman, P. Craven, L.R. Cox, N.J. Cundy, K. Dale, A. Feula, J. Frampton, M. Fung, M. Morton, A. Goff, M. Salih, X. Lang, X. Li, C. Moon, J. Pascoe, V. Portman, C. Press, T. Schulz-Utermoehl, S. Lee, M.D. Tortorella, Z. Tu, Z.E. Underwood, C. Wang, A. Yoshizawa, T. Zhang, S.J. Waddell, J. Bacon, L. Alderwick, J.S. Fossey, and C. Neagoie. Journal of Medicinal Chemistry, 2024. 67(4): p. 2529-2548. PMID[38331432]. PMCID[PMC10895678].
[PubMed]. TB_02_2024.

6. Synthesis and Dihydrofolate Reductase Inhibitory Activity of 2-Amino-6-(arylaminomethyl) thieno 2,3-d pyrimidin-4(3H)-ones. Dailide, M. and S. Tumkevicius. Chemija, 2023. 34(3): p. 144-153. ISI[001112907800004].
[WOS]. TB_02_2024.

7. Synthesis and Anti-bacterial Activity Evaluation against Mycobacterium tuberculosis of New Quinoline Derivatives Coupled with the Camphor Nucleus. de Andrade, G.F., E.T. da Silva, M.C.S. Lourenço, S. Wardell, J.L. Wardell, and M.V.N. de Souza. Letters in Organic Chemistry, 2024. 21(2): p. 107-115. ISI[001156556600005].
[WOS]. TB_02_2024.

8. Novel Indolinone-tethered Benzothiophenes as Anti-tubercular Agents against MDR/XDR M. tuberculosis: Design, Synthesis, Biological Evaluation and In Vivo Pharmacokinetic Study. Eldehna, W.M., S.T. Mahmoud, E.R. Elshnawey, Z.M. Elsayed, T.A. Majrashi, M.K. El-Ashrey, M. Rashed, L.R. Hemeda, A.A. Shoun, E.B. Elkaeed, M.A. El Hassab, M.M. Abdel-Aziz, and M.I. Shahin. Bioorganic Chemistry, 2024. 143: 107009. PMID[38070474].
[PubMed]. TB_02_2024.

9. Synthesis and Biological Evaluation of N-Benzylindolylchalcone Analogs as Antitubercular Agents. Joshi, S. and N. Kawathekar. Indian Journal of Heterocyclic Chemistry, 2023. 33(3): p. 349-354. ISI[001159395900009].
[WOS]. TB_02_2024.

10. New Azaaurone Derivatives as Potential Multitarget Agents in HIV-TB Coinfection. Leite, D.I., A. Campaniço, P.A.G. Costa, I.A. Correa, L.J. da Costa, M.M. Bastos, R. Moreira, F. Lopes, A. Jordaan, D.F. Warner, and N. Boechat. Archiv der Pharmazie, 2024. 357(2): e2300560. PMID[38032154].
[PubMed]. TB_02_2024.

11. Expanding the Chemical Diversity of Grisechelins via Heterologous Expression. Liu, W., S. Zhai, L. Zhang, Y. Chen, Z. Liu, W. Ma, T. Zhang, W. Zhang, L. Ma, C. Zhang, and W. Zhang. Journal of Natural Products, 2024. 87(2): p. 371-380. PMID[38301035].
[PubMed]. TB_02_2024.

12. Some New Benzotriazole Derivatives: Synthesis, Antimycobacterial Evaluation, Antimicrobial Efficacy, ADME Studies, and Molecular Docking Studies. Maiti, N.J. and S. Ganguly. Indian Journal of Heterocyclic Chemistry, 2023. 33(3): p. 385-392. ISI[001159395900014].
[WOS]. TB_02_2024.

13. Nitric oxide-releasing Prodrug for the Treatment of Complex Mycobacterium abscessus Infections. McDonald, R.A., S.G. Nagy, M. Chambers, C.A. Broberg, M.J.R. Ahonen, and M.H. Schoenfisch. Antimicrobial Agents and Chemotherapy, 2024. 68(2): e0132723. PMID[38206003]. PMCID[PMC10848776].
[PubMed]. TB_02_2024.

14. In Vitro Antimycobacterial Activity of Aqueous and Alcoholic Leaves Extracts of Plumeria alba against Mycobacterium kansasii. Nanda, J., M. Asif, O. Abdulaziz, M. Allahyani, A. Aljuaid, A.A. Alsaiari, M. Almehmadi, and S. Verma. Latin American Journal of Pharmacy, 2023. 42(10): p. 2016-2020. ISI[001149817600011].
[WOS]. TB_02_2024.

15. Combined Application of Juniperus communis Essential Oil and Amikacin, Clarithromycin and Rifampicin against Mycobacterium avium and Mycobacterium intracellulare. Peruc, D., S. Stifter-Vretenar, A. Planinic, and I. Gobin. Processes, 2024. 12(1): 111. ISI[001152438900001].
[WOS]. TB_02_2024.

16. High Efficacy of the F-ATP Synthase Inhibitor TBAJ-5307 against Nontuberculous Mycobacteria In Vitro and In Vivo. Ragunathan, P., P. Sae-Lao, C. Hamela, M. Alcaraz, A. Krah, W.H. Poh, C.J. Ern Pee, A.Y. Hou Lim, S.A. Rice, K. Pethe, P.J. Bond, T. Dick, L. Kremer, R.W. Bates, and G. Grüber. Journal of Biological Chemistry, 2024. 300(2): 105618. PMID[38176652]. PMCID[PMC10840338].
[PubMed]. TB_02_2024.

17. Investigation of New 1,2,3-triazolyl-quinolinyl-propan-2-ol Derivatives as Potential Antimicrobial Agents: In Vitro and In Silico Approach. Shinde, A.D., Y.M. Nandurkar, S. Bhalekar, Y.S. Walunj, S. Ugale, I. Ahmad, H. Patel, A.P. Chavan, and P.C. Mhaske. Journal of Biomolecular Structure and Dynamics, 2024. 42(3): p. 1191-1207. PMID[37254438].
[PubMed]. TB_02_2024.

18. Identification and Optimization of Pyridine Carboxamide-based Scaffold as a Drug Lead for Mycobacterium tuberculosis. Singh, P., A. Kumar, P. Sharma, S. Chugh, A. Kumar, N. Sharma, S. Gupta, M. Singh, S. Kidwai, J. Sankar, N. Taneja, Y. Kumar, R. Dhiman, D. Mahajan, and R. Singh. Antimicrobial Agents and Chemotherapy, 2024. 68(2): e0076623. PMID[38193667]. PMCID[PMC10848774].
[PubMed]. TB_02_2024.

19. Omadacycline Pharmacokinetics/Pharmacodynamics and Efficacy against Multidrug-resistant Mycobacterium tuberculosis in the Hollow Fiber System Model. Singh, S., T. Gumbo, G.D. Boorgula, T.A. Thomas, J.V. Philley, and S. Srivastava. Antimicrobial Agents and Chemotherapy, 2024. 68(2): p. e0108023. PMID[38131673]. PMCID[PMC10848755].
[PubMed]. TB_02_2024.

20. Exploring the Plasticity of the InhA Substrate-binding Site Using New Diaryl ether Inhibitors. Tamhaev, R., E. Grosjean, H. Ahamed, M. Chebaiki, F. Rodriguez, D. Recchia, G. Degiacomi, M.R. Pasca, L. Maveyraud, L. Mourey, and C. Lherbet. Bioorganic Chemistry, 2024. 143: 107032. PMID[38128204].
[PubMed]. TB_02_2024.

21. Metabolites from Streptomyces aureus (VTCC43181) and their Inhibition of Mycobacterium tuberculosis ClpC1 Protein. Tran, T.T.P., N.N.T. Huynh, N.T. Pham, D.T. Nguyen, C.V. Tran, U.Q. Nguyen, A.N. Ho, J.W. Suh, J.H. Cheng, T.K.N. Nguyen, S.V. Tran, and D.M. Nguyen. Molecules, 2024. 29(3): 720. PMID[38338462]. PMCID[PMC10856564].
[PubMed]. TB_02_2024.

22. Synthesis and Antitubercular Evaluation of Diverse Glycosylated Ureas from D-Glucose. Tripathi, N. and V.K. Tiwari. Journal of Chemistry, 2024. 2024: 8709672. ISI[001159495700001].
[WOS]. TB_02_2024.

23. Syringaldehyde Exhibits Antibacterial and Antioxidant Activities against Mycobacterium marinum Infection. Wen, D., C. Meng, Y. Feng, L. Shen, Y. Liu, W. Sun, G. Chen, and C. Wu. Microorganisms, 2024. 12(2): 348. PMID[38399751]. PMCID[PMC10893232].
[PubMed]. TB_02_2024.

24. Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis. Yang, L., X. Hu, Y. Lu, R. Xu, Y. Xu, W. Ma, M.S. Alam, T. Zhang, X. Chai, Y. Lei, Q. Ye, X. Dong, Y. Kang, J. Che, T. Hou, and D. Li. Journal of Medicinal Chemistry, 2024. 67(3): p. 1914-1931. PMID[38232131].
[PubMed]. TB_02_2024.

25. An Anti-mycobacterial Conjugated Oligoelectrolyte Effective against Mycobacterium abscessus. Zhang, K., J. Limwongyut, A.S. Moreland, S.C.J. Wei, T. Jim Jia Min, Y. Sun, S.J. Shin, S.Y. Kim, B.W. Jhun, K. Pethe, and G.C. Bazan. Science Translational Medicine, 2024. 16(735): eadi7558. PMID[38381846].
[PubMed]. TB_02_2024.

26. Sudapyridine (WX-081) Antibacterial Activity against Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium chelonae In Vitro and In Vivo. Zheng, L., H. Wang, X. Qi, W. Zhang, B. Wang, L. Fu, X. Chen, X. Chen, and Y. Lu. mSphere, 2024. 9(2): e0051823. PMID[38240581]. PMCID[PMC10900899].
[PubMed]. TB_02_2024.

Patent Citations

27. N2,N4-Disubstituted pyrimidine-2,4-diamine Compounds as Antibacterial Agents. Haroun, M. and C. Tratrat. Patent. 2024. US2023-134693 11891362: 13 pp.
[Patent]. TB_02_2024.

28. Azolylpiperidinyl-ethanones as Small-molecule Activators of Mycobacterium tuberculosis Adenylyl cyclase and Their Preparation. Qin, B., C. McNamara, A. Chatterjee, M.H. Petrassi, M. Love, S. Joseph, A. Woods, B.C. Vanderven, and D.G. Russell. Patent. 2024. WO2022-US39160 2024030121: 189 pp.
[Patent]. TB_02_2024.

29. Coumarin Compounds as Antibacterial Agents. Tratrat, C. and M. Haroun. Patent. 2024. US2023-119751 11897859: 14 pp.
[Patent]. TB_02_2024.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024